The Emerging Role of PARP Inhibitors in the Maintenance Setting for Patients With Advanced Pancreatic Cancer

Activity

Progress
1
Course Completed
Activity Information

Released: March 05, 2021

Expiration: March 04, 2022

Paul E. Oberstein
Paul E. Oberstein, MD